Talk about urology

Risk stratification for localized #ProstateCancer. Matthew Cooperberg, MD, MPH, FACS UCSF joins Charles Ryan, MD Prostate Cancer Foundation discussing which patients should recieve #ActiveSurveillance and who should not. #WatchNow on UroToday

 https://www.urotoday.com/video-lectures/localized-prostate-cancer/video/mediaitem/2557-risk-stratification-for-localized-prostate-cancer-matthew-cooperberg.html?mtm_campaign=Cooperberg_SocialVideo_ID2557&fbclid=IwAR2eGV58B2oLKuxzDqzlCO4R7xLDN_OfYLKHu-W4ZBSSc0QB9Ty_-IhJSWU

Read more

#Lantheus’ PYLARIFY AI™ Platform demonstrates higher efficiency and consistency while maintaining accuracy for assessment of PSMA imaging in #ProstateCancer. #ReadNow details on UroToday

 https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/137848-lantheus-pylarify-ai-platform-demonstrates-higher-efficiency-and-consistency-while-maintaining-accuracy-for-assessment-of-psma-imaging-in-prostate-cancer.html?mtm_campaign=Lantheus_SocialPressRelease_ID137848&fbclid=IwAR2nI3fj-ZGqMSAs1CCkQSMxPbpx1GFqpi5FC5zEu8M8QqhbGrd7WeEd5XA

Read more

Treatment and survival differences in patients with urothelial vs nonurothelial bladder & upper tract carcinomas. Jeanny Aragon-Ching, MD Inova Schar Cancer Institute joins Sam Chang, MD, MBA Vanderbilt Health discussing a retrospective review she presented at #GU22

https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/137848-lantheus-pylarify-ai-platform-demonstrates-higher-efficiency-and-consistency-while-maintaining-accuracy-for-assessment-of-psma-imaging-in-prostate-cancer.html?mtm_campaign=Lantheus_SocialPressRelease_ID137848&fbclid=IwAR2nI3fj-ZGqMSAs1CCkQSMxPbpx1GFqpi5FC5zEu8M8QqhbGrd7WeEd5XA 

Read more

The importance of multidisciplinary collaboration in #Urology clinics. Neal Shore, MD, FACS Atlantic Urology Clinics joins Alicia Morgans, MD, MPH Dana-Farber Cancer Institute to discuss work presented in a plenary presentation at #AUA22

https://www.urotoday.com/video-lectures/mhspc/video/mediaitem/2667-the-importance-of-multidisciplinary-collaboration-in-urology-clinics-neal-shore.html?mtm_campaign=Shore_Socialvideo_ID2667&fbclid=IwAR1wWGV3B_zVptw314ISphZvhX43RgR2nhn26e8TitYahaAwGD_tqC0YIYI 

Read more

Future targets for cellular therapy in #ProstateCancer. Presentation by Vivek Narayan, MD, MS University of Pennsylvania. #ASCO22 written coverage by Alok Tewari, MD, PhD Dana-Farber Cancer Institute on UroToday

https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137786-asco-2022-future-targets-for-cellular-therapy-in-prostate-cancer.html?mtm_campaign=Narayan_SocialASCO22_ID137786&fbclid=IwAR1xmWq7YcG0wrU75f7oUGRXioA6ypQUZSTpwodpQJ2h9PX5mf47kjEwedk 

Read more

Treatment considerations in advanced #ProstateCancer. Bertrand Tombal, MD, PhD UCLouvain – Université catholique de Louvain joins Alicia Morgans, MD, MPH Dana-Farber Cancer Institute to discuss #ARASENS and #PEACE1 data as well as the messages around maximal androgen blockade and PARP inhibitors

https://www.urotoday.com/video-lectures/asco-gu-2022/video/mediaitem/2504-treatment-considerations-in-advanced-prostate-cancer-bertrand-tombal.html?mtm_campaign=Tombal_SocialVideo_ID2504&fbclid=IwAR0wf5zA0qE2bJn9nyGc2GlDUdgoLrceotOWGFyRaPhJ4iI_v0ZSjbcwHEM 

Read more

#BrightUro launches with $6 Million in seed financing and grant from the National Institutes of Health (NIH). #PressRelease #ReadNow details on UroToday

https://www.urotoday.com/recent-abstracts/pelvic-health-reconstruction/overactive-bladder/137803-bright-uro-launches-with-6-million-in-seed-financing-and-grant-from-national-institutes-of-health.html?mtm_campaign=BrightUro_SocialPressRelease_ID137803&fbclid=IwAR0Yx5YEOckNJKYihAFBMsn9RF29A0rWWoTc4eV0ih9OLls3f9gc5oOiEWQ 

Read more

Introduction as well as panel question & answer. Presentation by David VanderWeele, MD, PhD Northwestern University Feinberg School of Medicine #ASCO22 written coverage by Alok Tewari, MD, PhD Dana-Farber Cancer Institute

https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137787-asco-2022-introduction-as-well-as-panel-question-and-answer.html?mtm_campaign=VanderWeele_SocialASCO22_ID137787&fbclid=IwAR2t51vSdr6wBDGAm9vwxK2hLnH7M2MbW73CzgtkXIAFQdvk1RDAMTjllPw 

Read more

Bispecific T-cell engager (BiTE®) in development for treatment of advanced #ProstateCancer. Oliver Sartor, MD Tulane Cancer Center joins Alicia Morgans, MD, MPH Dana-Farber Cancer Institute to discuss the evolving landscape of BiTE® technology in prostate cancer therapy.

 https://www.urotoday.com/video-lectures/mcrpc-treatment/video/mediaitem/2401-bispecific-t-cell-engager-bite-in-development-for-treatment-of-advanced-prostate-cancer-oliver-sartor.html?mtm_campaign=Sartor_SocialVideo_2401&fbclid=IwAR3Y0ca_aAZQc_69TosqLiLNROOxN8iS56wkQWNQ3TYsimV9TtzGZdrpIjU

Read more

The Prostate Cancer Foundation Team Science #TACTICAL Awards. Howard Soule, MD joins Charles Ryan, MD to discuss the new team science award as part of a broader novel Therapy ACceleration To Intercept CAncer Lethality (TACTICAL) campaign. #WatchNow on UroToday

https://www.urotoday.com/video-lectures/pcf-2021/video/mediaitem/2584-the-prostate-cancer-foundation-team-science-tactical-awards-howard-soule.html?mtm_campaign=SoulePCF_SocialVideo_2584&fbclid=IwAR2b37FUIzJkaTsbTg5PfR_cWwDzitBAMq2A5ggmCUjcKaBeXwF_WetmY-4 

Read more
Загрузить еще